Latest News and Press Releases
Want to stay updated on the latest news?
-
INDIANAPOLIS, May 24, 2024 (GLOBE NEWSWIRE) -- Today during the Indiana Global Economic Summit, Governor Eric J. Holcomb, chairman of the Indiana Economic Development Corporation, joined Eli Lilly...
-
Covina, Feb. 12, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Biopharmaceutical and Biomedicine Market size was valued at about USD 570.0 Billion in 2024 and expected to...
-
COLUMBUS, Ohio, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
-
Covina, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Axial Spondyloarthritis affects joints in axial skeleton such as chest, pelvis and spine. Skin and nail changes of Psoriasis, longstanding low back pain,...
-
Hyderabad, July 27, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “ Biopharmaceuticals Market Report (2023-2028),” the market is estimated at USD 478.20 billion in 2023....
-
Hyderabad, July 03, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Insulin Market Report (2023-2028)," the market is estimated at USD 26.92 billion in 2023. It is...
-
COLUMBUS, Ohio, May 25, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
-
Portland, OR, Nov. 25, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global High Potency APIs Market generated $19.7 billion in 2021, and is...
-
Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Joint Pain Injections Market size garnered $6.3 billion in 2021, and...
-
COLUMBUS, Ohio, May 31, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...